Baillonella toxisperma
Baillonella toxisperma · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Baillonella toxisperma is a remarkable plant species that has gained significant interest due to its diverse therapeutic potential. Research indicates that a hydroethanolic extract derived from its fruit exhibits potent antibacterial and antihyperglycemic activities. The plant is notably rich in bioactive compounds, including flavonoids, epicatechin, epigallocatechin, and epigallocatechin gallate. These chemical constituents suggest that the plant may play a role in managing health conditions such as asthma and reducing cardiovascular risk. Consequently, this species serves as a promising subject for further pharmacological investigation.
- Synonyms
- Mimusops Djave · Baillonella Djave · 3 more
- Common names
- Not available
- Family
- Sapotaceae
- Distribution
- Not available
- Plant Parts
- Fruit
Classification
Common Names
Baillonella toxisperma is a remarkable tree known by many different names across various cultures and languages. In many regions, it is widely recognized by its common names, such as African Pearwood and Djave Nut. It is also frequently referred to as Moabi, a name that carries significant weight in its native habitats. In certain linguistic contexts, it is identified as bajlonela jedovatá, while in Japan, it is known as モアビ. This diversity of nomenclature highlights the global interest and widespread presence of this unique species.
Sources: Catalogue of Life (COL)
Synonyms
Baillonella toxisperma is a complex species that has been identified by several different botanical names throughout history. Scientific literature frequently lists synonyms such as Baillonella djave and Baillonella pierriana to describe various classifications of the plant. Further taxonomic variations include the specific designation of Baillonella toxisperma var. obovata. The species is also closely linked to older nomenclature, including the names Mimusops djave and Mimusops pierreana. Understanding these overlapping relationships is essential for accurate identification and botanical study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Baillonella toxisperma belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this kingdom, it is classified under the class Equisetopsida, marking its place among the flowering plants. The species is further organized into the order Ericales, which dictates many of its biological characteristics. It is a prominent member of the genus Baillonella, showcasing unique evolutionary traits. Finally, this plant is a distinguished representative of the family Sapotaceae.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ericales |
| Family | Sapotaceae |
| Genus | Baillonella |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Baillonella toxisperma is a significant tree species widely distributed across several regions of the African continent. Its presence is notable throughout West Tropical Africa, particularly within the borders of Nigeria. The species also flourishes in West-Central Tropical Africa, spanning territories such as Cabinda and Cameroon. Furthermore, its natural habitat extends into the Central African Republic and the Congo. This broad geographic range highlights the plant's adaptability to various tropical environments across the region.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Baillonella toxisperma is a magnificent tree that grows in a self-supporting form. This impressive species is known for its massive scale, reaching significant heights in its natural habitat. Typically, it stands at a minimum height of 50 meters. At its full maturity, the tree can soar to a maximum height of 60 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Baillonella toxisperma is a medicinal plant that exhibits significant therapeutic potential through its diverse biological activities. Research into its bark has revealed potent antibacterial properties, which are attributed to various identified compounds such as flavonoids and stilbenes. Beyond combating microbial diseases, the plant also offers promising benefits for metabolic health. Specifically, hydroethanolic extracts from its fruit have demonstrated strong antihyperglycemic effects by significantly reducing blood glucose levels in diabetic models. These combined findings suggest that both the bark and fruit of B. toxisperma could serve as valuable natural sources for managing infections and diabetes.
Compounds
Baillonella toxisperma is a medicinal plant from northern Gabon that has gained scientific attention for its significant therapeutic potential. Recent chemical investigations into its bark have successfully identified several key bioactive compounds through advanced molecular networking. Specifically, researchers discovered that the plant contains the flavonoid epicatechin. The analysis further revealed the presence of epigallocatechin within the botanical sample. Additionally, the study confirmed that Baillonella toxisperma contains epigallocatechin gallate, contributing to its complex phytochemical profile.
Conditions
Baillonella toxisperma demonstrates significant therapeutic potential in the management of diabetes by reducing glucose concentrations and regulating glycemic peaks. The hydroethanolic extract of its fruit also acts to decrease cardiovascular risk in diabetic subjects. Specifically, this plant treats the Cardiac Risk Ratio and the Atherogenic Coefficient through the reduction of plasma triglycerides and total cholesterol levels. While other medicinal species are noted for asthma in ethnobotanical surveys, the provided data focuses on the metabolic benefits of this specific plant. Therefore, Baillonella toxisperma serves as a promising source of compounds for addressing both diabetic and cardiovascular concerns.
Preparations
Baillonella toxisperma is prepared as a hydroethanolic extract specifically from its fruit pulp. This particular preparation is utilized to evaluate significant antihyperglycemic and antihyperlipidemic activities in diabetic models. Research indicates that the hydroethanolic extract of the fruit can effectively limit glycemic peaks following the consumption of starch and sucrose. Furthermore, the extract demonstrates the ability to decrease plasma triglycerides and total cholesterol levels in subjects. Consequently, this hydroethanolic preparation of Baillonella toxisperma serves as a potential source of compounds for managing diabetes.
Parts used
Baillonella toxisperma contains a fruit that serves as a significant source of medicinal compounds. Research indicates that hydroethanolic extracts derived from the pulp of these fruits possess notable antihyperglycemic and antihyperlipidemic properties. In experimental studies, the extract successfully reduced glucose concentrations and limited glycemic peaks after the consumption of starch and sucrose. Furthermore, the fruit extract helped decrease plasma triglycerides and total cholesterol levels, which effectively lowered cardiovascular risk in diabetic subjects. These findings suggest that the fruit of B. toxisperma could be a valuable natural resource for managing diabetes and related metabolic complications.